Suppr超能文献

天然植物产品在肺动脉高压治疗中的应用

Natural plant products in treatment of pulmonary arterial hypertension.

作者信息

Xiang Lili, Li Ying, Deng Xu, Kosanovic Djuro, Schermuly Ralph Theo, Li Xiaohui

机构信息

1 Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha, China.

2 Department of Health Management, The Third Xiangya Hospital, Central South University, Changsha, China.

出版信息

Pulm Circ. 2018 Jul-Sep;8(3):2045894018784033. doi: 10.1177/2045894018784033. Epub 2018 Jun 5.

Abstract

Pulmonary arterial hypertension (PAH) is a severe disease characterized by progressive remodeling of distal pulmonary arteries and persistent elevation of pulmonary vascular resistance (PVR), which leads to right ventricular dysfunction, heart failure, and eventually death. Although treatment responsiveness for this disease is improving, it continues to be a life-threatening condition. With the clinical efficacy of natural plant products being fully confirmed by years of practice, more and more recognition and attention have been obtained from the international pharmaceutical industry. Moreover, studies over the past decades have demonstrated that drugs derived from natural plants show unique advantages and broad application prospects in PAH treatment, not to mention the historical application of Chinese traditional medicine in cardiopulmonary diseases. In this review, we focus on summarizing natural plant compounds with therapeutic properties in PAH, according to the extracts, fractions, and pure compounds from plants into categories, hoping it to be helpful for basic research and clinical application.

摘要

肺动脉高压(PAH)是一种严重疾病,其特征为远端肺动脉进行性重塑和肺血管阻力(PVR)持续升高,进而导致右心室功能障碍、心力衰竭,最终死亡。尽管该疾病的治疗反应性正在改善,但它仍然是一种危及生命的病症。随着天然植物产品的临床疗效在多年实践中得到充分证实,其已获得国际制药行业越来越多的认可和关注。此外,过去几十年的研究表明,源自天然植物的药物在PAH治疗中显示出独特优势和广阔应用前景,更不用说传统中药在心肺疾病方面的历史应用了。在本综述中,我们着重根据植物提取物、馏分和纯化合物对具有PAH治疗特性的天然植物化合物进行分类总结,希望对基础研究和临床应用有所帮助。

相似文献

1
Natural plant products in treatment of pulmonary arterial hypertension.天然植物产品在肺动脉高压治疗中的应用
Pulm Circ. 2018 Jul-Sep;8(3):2045894018784033. doi: 10.1177/2045894018784033. Epub 2018 Jun 5.
4
Management of pulmonary arterial hypertension.肺动脉高压的管理。
J Am Coll Cardiol. 2015 May 12;65(18):1976-97. doi: 10.1016/j.jacc.2015.03.540.
5
Endothelin receptor antagonists for pulmonary arterial hypertension.用于治疗肺动脉高压的内皮素受体拮抗剂。
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004434. doi: 10.1002/14651858.CD004434.pub3.

引用本文的文献

4
Nanomedicine of Plant Origin for the Treatment of Metabolic Disorders.用于治疗代谢紊乱的植物源纳米医学
Front Bioeng Biotechnol. 2022 Feb 11;9:811917. doi: 10.3389/fbioe.2021.811917. eCollection 2021.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验